Search
01/10/2023
Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus
Crespo-Lessmann A., Marqués-Espi J.A., Dominguez-Ortega J., Perez de Llano L., Blanco-Aparicio M., Santiñá M., Palop-Cervera M., Álvarez F.J., Fraj J.. Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus. Journal Of Healthcare Quality Research. 2023; 38(5)DOI:10.1016/j.jhqr.2023.03.003. PMID:37003928. IF:(Q/D).
01/10/2023
Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries
Martínez-García M.Á., Oscullo G., Gómez-Olivas J.D., Olveira C., Girón R., García-Clemente M., Máiz L., Sibila O., Golpe R., Rodríguez-Hermosa J.L., Barreiro E., Méndez R., Prados C., Rodríguez-López J., De La Rosa D.. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(10)DOI:10.1016/j.arbres.2023.07.023. PMID:37563019. IF:(Q/D).
01/10/2023
Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
Orgueira, AM, Encinas, MMP, Varela, NAD, Mora, E, Díaz-Beyá, M, Montoro, MJ, Pomares, H, Ramos, F, Tormo, M, Jerez, A, Nomdedeu, JF, Sanchez, CD, Leonor, A, Cárcel, P, Romero, MTC, Xicoy, B, Rivero, E, Barreto, RAD, Diez-Campelo, M, Benlloch, LE, Crucitti, D, Valcárcel, D. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes. Hemasphere. 2023; 7(10)DOI:10.1097/HS9.0000000000000961. PMID:37841754. IF:11.900(Q1/1D).
01/10/2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients
Piñana, JL, Heras, I, Aiello, TF, García-Cadenas, I, Vazquez, L, Lopez-Jimenez, J, Chorao, P, Aroca, C, García-Vidal, C, Arroyo, I, Soler-Espejo, E, López-Corral, L, Avendaño-Pita, A, Arrufat, A, Garcia-Gutierrez, V, Arellano, E, Hernández-Medina, L, González-Santillana, C, Morell, J, Hernández-Rivas, JA, Rodriguez-Galvez, P, Mico-Cerdá, M, Guerreiro, M, Campos, D, Navarro, D, Cedillo, A, Martino, R, Solano, C. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients. Viruses-Basel. 2023; 15(10)DOI:10.3390/v15102066. PMID:37896843. IF:3.800(Q2/5D).
01/10/2023
Programa de optimización de antibioterapia en infección urinaria por cepas multirresistentes en el servicio de urgencias.
Ruiz-Ramos J, Herrera-Mateo S, Rivera-Martínez MA, Monje-López AE, Hernández-Ontiveros H, Pereia-Batista CS, Martinez-Ysasis YM, Puig-Campmany M. Programa de optimización de antibioterapia en infección urinaria por cepas multirresistentes en el servicio de urgencias.. Revista Espanola de Quimioterapia. 2023; 36(5)DOI:10.37201/req/009.2023. PMID:37458335. IF:1.900(Q3/7D).
01/10/2023
On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome
Huerta A., Arjona E., Portoles J., Lopez-Sanchez P., Cavero T., Fernandez-Cusicanqui J., Blasco M., Cabello V., Calvo N., Diaz M., Herrero-Goñi M., Aguirre M., Elías S., Alcaide M.P., Ramos N., Sellares J., Rodríguez de Córdoba S.. On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome. KIDNEY INTERNATIONAL. 2023; 104(4)DOI:10.1016/j.kint.2023.07.020. PMID:37567446. IF:14.800(Q1/1D).